This topic contains a solution. Click here to go to the answer

Author Question: Which of the following will NOT increase the resistance to organizational change? A) groupthink ... (Read 19 times)

lilldybug07

  • Hero Member
  • *****
  • Posts: 546
Which of the following will NOT increase the resistance to organizational change?
 
  A) groupthink
  B) escalation of commitment
  C) weak organizational norms
  D) group cohesiveness

Question 2

Which of the following is not true of stress?
 
  A) Some stress can be positive.
  B) One should reduce dysfunctional stress.
  C) One needs to avoid all stressors.
  D) At times stress leads to innovation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

helenmarkerine

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

C

Answer to Question 2

C




lilldybug07

  • Member
  • Posts: 546
Reply 2 on: Jul 7, 2018
Wow, this really help


zacnyjessica

  • Member
  • Posts: 345
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library